News from EAS 2024: Anti-inflammatory effects GLP-1RA in T2D

Anti inflammatory effects of semaglutide in diabetes

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
EAS 2024
Novel PCSK9 inhibitor lowers LDL-c in another large phase 3 study
- Evan Stein, MD, PhD
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
EAS 2024
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
Causal relationship between elevated Lp(a) levels and CKD risk
Causal relationship between elevated Lp(a) levels and CKD risk
EAS 2024
Causal relationship between elevated Lp(a) levels and CKD risk
- Anne Langsted, MD, PhD
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
EAS 2024
Encouraging data with APOC3 siRNA in mixed hyperlipidemia
- Christie Ballantyne, MD